These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26908079)

  • 41. Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2.
    Szalai K; Fuhrmann J; Pavkov T; Scheidl M; Wallmann J; Brämswig KH; Vrtala S; Scheiner O; Keller W; Saint-Remy JM; Neumann D; Pali-Schöll I; Jensen-Jarolim E
    Mol Immunol; 2008 Mar; 45(5):1308-17. PubMed ID: 17964653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired allergy diagnostics among parasite-infected patients caused by IgE antibodies to the carbohydrate epitope galactose-α 1,3-galactose.
    Arkestål K; Sibanda E; Thors C; Troye-Blomberg M; Mduluza T; Valenta R; Grönlund H; van Hage M
    J Allergy Clin Immunol; 2011 Apr; 127(4):1024-8. PubMed ID: 21376382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis.
    Worm M; Patel D; Creticos PS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1347-57. PubMed ID: 23964728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of cat dander-specific T lymphocytes from atopic patients.
    van Neerven RJ; van de Pol MM; van Milligen FJ; Jansen HM; Aalberse RC; Kapsenberg ML
    J Immunol; 1994 Apr; 152(8):4203-10. PubMed ID: 8144980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.
    Hulse KE; Reefer AJ; Engelhard VH; Satinover SM; Patrie JT; Chapman MD; Woodfolk JA
    J Allergy Clin Immunol; 2008 Mar; 121(3):756-762.e4. PubMed ID: 18086491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins.
    Finlay WJ; deVore NC; Dobrovolskaia EN; Gam A; Goodyear CS; Slater JE
    Clin Exp Allergy; 2005 Aug; 35(8):1040-8. PubMed ID: 16120086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
    Rudulier CD; Tonti E; James E; Kwok WW; Larché M
    Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity.
    Nilsson OB; Adedoyin J; Rhyner C; Neimert-Andersson T; Grundström J; Berndt KD; Crameri R; Grönlund H
    PLoS One; 2011; 6(9):e24558. PubMed ID: 21931754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
    Thoms F; Jennings GT; Maudrich M; Vogel M; Haas S; Zeltins A; Hofmann-Lehmann R; Riond B; Grossmann J; Hunziker P; Fettelschoss-Gabriel A; Senti G; Kündig TM; Bachmann MF
    J Allergy Clin Immunol; 2019 Jul; 144(1):193-203. PubMed ID: 31056187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis of allergen cross-reactivity: non-specific lipid transfer proteins from wheat flour and peach fruit as models.
    Tordesillas L; Pacios LF; Palacin A; Quirce S; Armentia A; Barber D; Salcedo G; Diaz-Perales A
    Mol Immunol; 2009 Dec; 47(2-3):534-40. PubMed ID: 19846220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
    Alexander C; Ying S; B Kay A; Larché M
    Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IVN201--therapy with a construct containing functional fusion peptides.
    Rose H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():319-27; discussion 327-8. PubMed ID: 20799476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergen immunotherapy with cat allergen peptides.
    Kay AB; Larché M
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):391-9. PubMed ID: 15007637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergen mimotopes.
    Riemer A; Scheiner O; Jensen-Jarolim E
    Methods; 2004 Mar; 32(3):321-7. PubMed ID: 14962767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.
    Orengo JM; Radin AR; Kamat V; Badithe A; Ben LH; Bennett BL; Zhong S; Birchard D; Limnander A; Rafique A; Bautista J; Kostic A; Newell D; Duan X; Franklin MC; Olson W; Huang T; Gandhi NA; Lipsich L; Stahl N; Papadopoulos NJ; Murphy AJ; Yancopoulos GD
    Nat Commun; 2018 Apr; 9(1):1421. PubMed ID: 29650949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy.
    Martínez-Gómez JM; Johansen P; Rose H; Steiner M; Senti G; Rhyner C; Crameri R; Kündig TM
    Allergy; 2009 Jan; 64(1):172-8. PubMed ID: 19076537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and isolation of a Fel d 1-like molecule as a major rabbit allergen.
    Hilger C; Kler S; Arumugam K; Revets D; Muller CP; Charpentier C; Lehners C; Morisset M; Hentges F
    J Allergy Clin Immunol; 2014 Mar; 133(3):759-66. PubMed ID: 23763973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy.
    van Ree R; van Leeuwen WA; Bulder I; Bond J; Aalberse RC
    J Allergy Clin Immunol; 1999 Dec; 104(6):1223-30. PubMed ID: 10589005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.